Psychologists in Graeagle, CA Accepting Medicare
1 Psychologists found. Showing 1 - 1
 Laura Skillern Morrison, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 7597 Highway 89, Suite 4, Graeagle, CA 96103 Phone: 530-836-1800 Fax: 530-836-0472 |
News Archive
Viewpoints: Insurance safety net; Orszag on shift in health plans
In this country, three subjects that are guaranteed to generate a heated debate are religion, politics and, you guessed it, health insurance. Of the first two, Mark Twain observed that "people's beliefs and convictions are in almost every case gotten at second-hand."
Poll: 80% of American voters favor national school nutrition standards
Eighty percent of American voters favor national standards that would limit calories, fat, and sodium in snack and - la carte foods sold in U.S. schools and encourage the consumption of fruits, vegetables and low-fat dairy items, according to a new poll commissioned by the Kids' Safe & Healthful Foods Project, a joint project of The Pew Charitable Trusts and the Robert Wood Johnson Foundation.
Pioneering paper claims Earth's chemical energy powered early life
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
FDA schedules Advisory Committee meeting to review Orexigen's Contrave NDA
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
NBHA commends FDA for continuing investigation of bisphosphonate treatment for osteoporosis
In response to today's Perspective pieces published in the New England Journal Of Medicine, the National Bone Health Alliance (NBHA), a public-private partnership bringing together the expertise and resources of its 42 members from the private and non-profit sectors to collectively advance bone health and prevent disease, commends the U.S. Food and Drug Administration (FDA) for continuing to investigate the risks and benefits of long-term bisphosphonate treatment.
› Verified 8 days ago